This could lead to reduced time to market and lower costs for developers of cell ... development is based on a press release statement from Bio-Techne Corporation. For a comprehensive analysis ...

Beyond manufacturing capacity, sponsors seek expertise in specialized drug formulations, regulatory affairs, and service ...

Integrating best practices in AI, genomics, cell culture, and laboratory techniques together contribute to protein expression success.

Will Geist, President of Bio-Techne's Protein Science Segment, stated that the GMP TcBuster transposase is a significant advancement for cell therapy ... development is based on a press release ...

With that, I will turn the call to Dr. Agafonova to provide update on our clinical development program. Nataliya? Thank you, Wa'el, and good afternoon everyone. Our stem cell therapy, Lomecel-B ...

Since fiscal year 2015, area organizations received $108 million from the NIH, a Charlotte Observer analysis of NIH data ... of the human liver) for cell therapy. The researchers work in Charlotte ...

As a result, there is a need for continued innovation and increased efficiency in terms of drug development to manage cost ... between entities. “Cell therapy research has been built on ...

Zealand Pharma achieved notable organizational growth in 2024 with a 30% increase in the number of employees compared to 2023 ...

Starting in 2024, all such costs have ... The CMC has to be very, very clean, because we think this is incredibly challenging. I think you all know I come from a cell therapy background, obviously ...